Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
Sponsor: UConn Health
Summary
The goal of this clinical trial is to test the effects of MitoQ supplementation in older adults and frail older adults with physical dysfunction and/or cognitive dysfunction. The main question\[s\] it aims to answer are: * To compare vascular function, oxidative stress levels, and physical and cognitive function among older adults and frail older adults with physical and cognitive dysfunction * To determine whether MitoQ supplementation has the potential to improve vascular function in central and cerebral vessels * To determine whether MitoQ supplementation can enhance physical and cognitive capabilities.
Key Details
Gender
All
Age Range
65 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-10-07
Completion Date
2028-02-01
Last Updated
2026-01-09
Healthy Volunteers
Yes
Conditions
Interventions
Mitoquinone Mesylate
MitoQ given 20 mg per day for 12 weeks.
Placebo capsule
Placebo capsule taken every day for 12 weeks.
Locations (1)
UConn Health
Farmington, Connecticut, United States